Literature DB >> 2016318

Gene-specific formation and repair of cisplatin intrastrand adducts and interstrand cross-links in Chinese hamster ovary cells.

J C Jones1, W P Zhen, E Reed, R J Parker, A Sancar, V A Bohr.   

Abstract

We have used three methods to study the formation and repair of intrastrand adducts and interstrand cross-links in the DNA of Chinese hamster ovary cells induced by the anticancer drug cis-diamminedichloroplatinum II (cisplatin). Using atomic absorption spectroscopy, we found that 21% of the total genomic cisplatin adducts were removed at 8 h and 42% at 24 h. We used ABC excinuclease digestion, coupled with out previously reported methodology to quantify DNA in specific genomic regions. These adducts were removed faster in the transcribed dihydrofolate reductase and c-myc genes compared to a noncoding fragment, a region containing the little or nontranscribed c-fos oncogene, and to the overall genome. Interstrand cross-links in specific sequences were quantified by Southern hybridization of denatured-renatured DNA separated on a neutral gel. We found that cross-links were removed more efficiently from the gene regions than intrastrand adducts and, at high levels of cross-linking, removal was similar from transcribed and from nontranscribed regions.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2016318

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  34 in total

1.  Transcription-coupled and DNA damage-dependent ubiquitination of RNA polymerase II in vitro.

Authors:  Keng-Boon Lee; Dong Wang; Stephen J Lippard; Phillip A Sharp
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-19       Impact factor: 11.205

2.  A polymerase chain reaction-based method to detect cisplatin adducts in specific genes.

Authors:  M M Jennerwein; A Eastman
Journal:  Nucleic Acids Res       Date:  1991-11-25       Impact factor: 16.971

3.  XPF knockout via CRISPR/Cas9 reveals that ERCC1 is retained in the cytoplasm without its heterodimer partner XPF.

Authors:  Janin Lehmann; Christina Seebode; Sabine Smolorz; Steffen Schubert; Steffen Emmert
Journal:  Cell Mol Life Sci       Date:  2017-01-27       Impact factor: 9.261

4.  Assessment of DNA damage and repair in specific genomic regions by quantitative immuno-coupled PCR.

Authors:  M F Denissenko; S Venkatachalam; E F Yamasaki; A A Wani
Journal:  Nucleic Acids Res       Date:  1994-06-25       Impact factor: 16.971

5.  Damage-recognition proteins as a potential indicator of DNA-damage-mediated sensitivity or resistance of human cells to ultraviolet radiation.

Authors:  C C Chao
Journal:  Biochem J       Date:  1992-02-15       Impact factor: 3.857

6.  Elements That Regulate the DNA Damage Response of Proteins Defective in Cockayne Syndrome.

Authors:  Teruaki Iyama; David M Wilson
Journal:  J Mol Biol       Date:  2015-11-23       Impact factor: 5.469

7.  Decreased transcription-coupled nucleotide excision repair capacity is associated with increased p53- and MLH1-independent apoptosis in response to cisplatin.

Authors:  Lawton J Stubbert; Jennifer M Smith; Bruce C McKay
Journal:  BMC Cancer       Date:  2010-05-14       Impact factor: 4.430

8.  Preparation of mammalian expression vectors incorporating site-specifically platinated-DNA lesions.

Authors:  Wee Han Ang; William Wesley Brown; Stephen J Lippard
Journal:  Bioconjug Chem       Date:  2009-05-20       Impact factor: 4.774

9.  Increased gene-specific repair of cisplatin interstrand cross-links in cisplatin-resistant human ovarian cancer cell lines.

Authors:  W Zhen; C J Link; P M O'Connor; E Reed; R Parker; S B Howell; V A Bohr
Journal:  Mol Cell Biol       Date:  1992-09       Impact factor: 4.272

10.  Repair synthesis by human cell extracts in cisplatin-damaged DNA is preferentially determined by minor adducts.

Authors:  P Calsou; P Frit; B Salles
Journal:  Nucleic Acids Res       Date:  1992-12-11       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.